New research moves novel gene therapy for heart failure closer to the clinic
Knocking down the Hippo signaling pathway in pig cardiomyocytes after a heart attack, resulted in heart tissue renewal and improved function.
Read more
gene therapy
From the labs to patent; osteoarthritis gene-therapy product is moving toward clinical trials
More than 30 million people in the United States alone are affected by osteoarthritis (OA), a degenerative joint disease, and that number is expected to
Read more
The gene therapy watchers: Can an NIH advisory committee reinvent itself?
Francis Collins, NIH Director, and Scott Gottlieb, FDA Commissioner, recently announced plans to eliminate oversight of new gene therapy experiments by the NIH’s Recombinant DNA
Read more
Gene therapy offers potential treatment for osteoarthritis
Osteoarthritis is a multifactorial degenerative joint disorder that poses a major challenge for treatment. This condition currently affects 28 million people in the United States
Read more
Gene therapy: An out-of-body experience
On April 1, 2016, the European Medicines Agency (EMA) approved the first ex-vivo (outside the body) gene therapy in the Western Hemisphere. Diseased stem cells
Read more